Literature DB >> 17467991

Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors.

Gaétan Bour1, Sébastien Lalevée, Cécile Rochette-Egly.   

Abstract

Nuclear retinoic acid receptors (RARs) are transcriptional transregulators that control the expression of specific subsets of genes in a ligand-dependent manner. The basic mechanism for switching on gene transcription by agonist-liganded RARs involves their binding at specific response elements located in target genes. It also involves interactions with coregulatory protein complexes, the assembly of which is directed by the C-terminal ligand-binding domain of RARs. In addition to this scenario, several recent studies highlighted a fundamental role for the N-terminal domain in the transcriptional activity of RARs, following phosphorylation by the CDK7 kinase of the general transcription factor TFIIH and by p38MAPK. It has also emerged that the ubiquitin-proteasome system has a key role in RAR-mediated transcription. Here, we review new insights into how N-terminal domain and the proteasome pathway can influence the dynamics of RAR transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467991     DOI: 10.1016/j.tcb.2007.04.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  25 in total

1.  A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.

Authors:  Carlos Gorbea; Gregory Pratt; Vicença Ustrell; Russell Bell; Sudhir Sahasrabudhe; Robert E Hughes; Martin Rechsteiner
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

2.  High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.

Authors:  Amar B Singh; Rakeshwar S Guleria; Irina T Nizamutdinova; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

3.  Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.

Authors:  Nadine C Santos; Kwan Hee Kim
Journal:  Endocrinology       Date:  2010-03-09       Impact factor: 4.736

4.  A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters.

Authors:  Nathalie Bruck; Dominique Vitoux; Christine Ferry; Vanessa Duong; Annie Bauer; Hughes de Thé; Cécile Rochette-Egly
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

5.  Retinoic acid-gated sequence-specific translational control by RARalpha.

Authors:  Michael M Poon; Lu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

6.  SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3.

Authors:  Christine Ferry; Maurizio Gianni; Sébastien Lalevée; Nathalie Bruck; Jean-Luc Plassat; Ivan Raska; Enrico Garattini; Cécile Rochette-Egly
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

Review 7.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

8.  Site-specific and dose-dependent effects of glucocorticoid receptor phosphorylation in yeast Saccharomyces cerevisiae.

Authors:  Natasa Popovic; Sabera Ruzdijic; Dusan T Kanazir; Ana Niciforovic; Miroslav Adzic; Elissavet Paraskevopoulou; Constantia Pantelidou; Marija Radojcic; Constantinos Demonacos; Marija Krstic-Demonacos
Journal:  Steroids       Date:  2010-03-09       Impact factor: 2.668

Review 9.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929

10.  HACE1: A novel repressor of RAR transcriptional activity.

Authors:  Jianhua Zhao; Zhenping Zhang; Zivjena Vucetic; Kenneth J Soprano; Dianne Robert Soprano
Journal:  J Cell Biochem       Date:  2009-06-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.